We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TLX market cap is 4.63B. The company's latest EPS is AUD 0.0161 and P/E is 886.96.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 15.38M | 18.87M | 26.75M | 160.19M | 502.74M |
Operating Income | -28.36M | -42.89M | -76.95M | -90.81M | 51.08M |
Net Income | -27.87M | -44.89M | -80.51M | -104.08M | 5.21M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 102.61M | 157.82M | 109.81M | 255.35M | 398.3M |
Total Liabilities | 32.53M | 78.81M | 107.66M | 175.35M | 249.39M |
Total Equity | 70.08M | 79.02M | 2.16M | 80.01M | 148.91M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -23.33M | 1.96M | -59.33M | -63.97M | 23.88M |
Investing | -468k | -1.09M | -2.73M | -17M | -25.49M |
Financing | 42.72M | 34.12M | 2.85M | 174.96M | 10.19M |
Market Cap | 4.63B |
Price to Earnings Ratio | 886.96 |
Price to Sales Ratio | 9.2 |
Price to Cash Ratio | 37.54 |
Price to Book Ratio | 31.07 |
Dividend Yield | - |
Shares Outstanding | 323.98M |
Average Volume (1 week) | 1.45M |
Average Volume (1 Month) | 963.44k |
52 Week Change | 41.39% |
52 Week High | 14.46 |
52 Week Low | 8.20 |
Spread (Intraday) | 0.04 (0.28%) |
Company Name | Telix Pharmaceuticals Limited |
Address |
telix pharmaceuticals limited melbourne, victoria 3051 |
Website | https://www.telixpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions